New drug a breakthrough for brain tumor that strikes young people: NEJM editorial (IMAGE)

University of Virginia Health System

New drug a breakthrough for brain tumor that strikes young people: NEJM editorial

Caption

David Schiff, MD, the co-director of UVA Cancer Center’s Neuro-Oncology Center, has authored an editorial in the prestigious New England Journal of Medicine describing the potential significance of the drug vorasidenib for patients with tumors known as “grade 2 IDH-mutant gliomas.”

Credit

UVA Health

Usage Restrictions

May be used to accompany news coverage of the NEJM editorial. All other uses require express written permission from UVA Health.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.